Events

Rappel de Cobas IT 3000 Haematology Performance Suite, keyboard differential keyboard (with Cobas IT 3000 versions 2.03.08 to 2.04.00). An in vitro diagnostic medical device (IVD)

Selon Department of Health, Therapeutic Goods Administration, ce/cet/cette rappel concerne un dispositif en/au/aux/à Australia qui a été fabriqué par Roche Diagnostics Australia Pty Limited.

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • ID de l'événement
    RC-2012-RN-00782-3
  • Classe de risque de l'événement
    Class II
  • Date de mise en oeuvre de l'événement
    2012-08-08
  • Pays de l'événement
    Australia
  • Source de l'événement
    DHTGA
  • URL de la source de l'événement
    https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2012-RN-00782-3
  • Notes / Alertes
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Notes supplémentaires dans les données
  • Cause
    There is a potential that the analyte comments may be deleted if the specific analyte is not counted in the mask. this risk is avoided in the case that the user makes comments against the “blood film comments” analyte for reporting blood film comments. the differential keyboard orders a profile that contains all of the additional blood cell types that can be manually counted. in many instances these additional cell types will not be identified in the count and will not receive a result (eg blasts, myelocytes, etc). the expected behaviour is that if a cell is not counted, then these analytes will be removed from the profile when the final count is accepted.
  • Action
    Roche is providing work around instructions until a software upgrade can be implemented to permanently fix the issue.

Device

Cobas IT 3000 Haematology Performance Suite, keyboard differential keyboard (with Cobas IT 3000 v...
  • Modèle / numéro de série
    Cobas IT 3000 Haematology Performance Suite, keyboard differential keyboard (with Cobas IT 3000 versions 2.03.08 to 2.04.00). An in vitro diagnostic medical device (IVD)
  • Manufacturer
    Roche Diagnostics Australia Pty Limited

Manufacturer

Roche Diagnostics Australia Pty Limited